EHC publishes new issue of periodic review on advances in haemophilia treatment
EHC Now! Compilation Newsletter Sep ’18 – Jan ’19
The EHC Now! Compilation Newsletter gathering all EHC Now! articles from September 2018 to January 2019 is now out! In this edition, you will also find contributions from our Round Table sponsors. We hope...
Roche joins the EHC PARTNERS programme
Today Roche becomes the third company to join the European Haemophilia Consortium’s (EHC) innovative programme: Procurement of Affordable Replacement Therapies – Network of European Stakeholders (PARTNERS). This programme aims to improve access to medicines...
Medscape Offers Haemophilia Gene Therapy Education for Health Care Providers
After many years, gene therapy in patients with haemophilia has started to show promising results in alleviating symptoms and improving the disease phenotype. Medscape has launched a new education program for providers seeking to...
EHC and EAHAD release joint statement on novel non-replacement therapies
Registration for the 2018 EHC Inhibitor Summit is now open
After the great success of the two previous Inhibitor Summits organised by the European Haemophilia Consortium (EHC), we are delighted to announce the third annual EHC Inhibitor Summit that will take place in Barretstown,...
Call for EHC Youth Committee 2018-2020 Candidates
The EHC is currently looking for three youth candidates and an advisor to sit on its Youth Committee for the next three years (2018-2020) to support the development of the EHC Youth Leadership Workshop and other...
European Principles of Inhibitor Management have been published
In spite of recent major advances in the understanding and treatment of inhibitor development in patients with haemophilia, multidisciplinary management of many of these patients remains suboptimal and highly heterogenous across Europe. Following a...
Haemophilia Care in Europe 2018 Survey
Dear NMOs, Every three years since 2009, the EHC has carried out ‘Haemophilia Care in Europe’ surveys in order to determine the level of haemophilia treatment and care in countries across Europe, as well...
